BH31Y0Z
Magnetic Resonance Imaging (MRI) Breast, Left to None with Unenhanced and Enhanced, Other Contrast Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | B Imaging |
| Body System | H Skin, Subcutaneous Tissue and Breast |
| Operation | 3 Magnetic Resonance Imaging (MRI) |
| Body Part | 1 Breast, Left |
| Approach | Y Other Contrast |
| Device | 0 Unenhanced and Enhanced |
| Qualifier | Z None |
Operation Definition
Computer reformatted digital display of multiplanar images developed from the capture of radiofrequency signals emitted by nuclei in a body site excited within a magnetic field
Procedure Overview
This family describes MRI of the breast, a technique that uses a magnet and radio waves rather than X-rays to build detailed cross-sectional images of breast tissue. Because it does not rely on tissue density contrast the way mammography does, it can pick up soft tissue detail that is difficult to see on a standard film, particularly in women with dense breast tissue.
Breast MRI is commonly ordered for high-risk screening in women with a strong family history or genetic predisposition to breast cancer, for further evaluation of an ambiguous finding on mammogram or ultrasound, or to check the extent of a known cancer before surgical planning. It is also used after treatment to look for recurrence or to assess how well a tumor has responded to chemotherapy.
Coders should confirm from the report whether contrast was used, since breast MRI is almost always performed with intravenous gadolinium to highlight areas of abnormal blood flow, and a study without contrast would be unusual and worth double-checking against the technique section. Laterality again matters, as unilateral and bilateral studies are coded separately. A common error is failing to distinguish a diagnostic breast MRI ordered to characterize a specific abnormality from a high-risk screening MRI, since the clinical indication documented in the chart is what separates the two.
Anatomy & Axis Detail
Breast, Left
Breast MRI on the left side relies on magnetic resonance signal changes, usually after gadolinium-based contrast injection, to characterize glandular tissue and detect lesions based on how they enhance over time rather than on tissue density alone. This makes it particularly valuable for women with dense breasts, those undergoing high-risk screening due to genetic or familial cancer risk, or those needing further evaluation of an indeterminate finding on mammography or ultrasound involving the left breast. It also plays a role in staging a known left breast cancer, since it can reveal additional foci of disease or assess response to neoadjuvant chemotherapy. Correct lateral documentation matters because treatment and surgical decisions are made specifically from the left-sided findings.
Contrast: Other Contrast
Other Contrast captures imaging studies using a contrast medium that is neither high- nor low-osmolar iodinated agent, such as barium sulfate for gastrointestinal studies or gadolinium-based agents for certain applications outside standard MRI classification within this axis. It is used when the contrast administered does not fit the osmolarity-based iodinated categories, distinguishing it from those specific classes and from studies performed with no contrast.
Qualifier: Unenhanced and Enhanced
Unenhanced and Enhanced specifies that an imaging study was performed both before and after administration of contrast material, allowing comparison between the two phases. This is common in studies evaluating enhancement patterns of lesions, such as certain CT or MRI protocols. It differs from None, which reflects a purely unenhanced study, and from single-agent contrast qualifiers used elsewhere.
Coding & Documentation
Check the technique section for contrast administration, since its absence in a breast MRI report is atypical and should prompt a second look, and confirm laterality matches what the ordering provider documented as the area of concern.
Commonly Confused With
Breast MRI is sometimes confused with breast ultrasound or mammography when reports are reviewed quickly. The distinction is the imaging technology itself, magnetic resonance versus sound waves or X-rays, which is stated explicitly in the report header and technique description.